title: Endovascular Repair of Ruptured Infected Arteries as a Temporizing Measure Versus Destination Therapy.
abstract: OBJECTIVE
  Mycotic rupture of the arteries is a rare but deadly disorder. Current management typically involves open surgical repair. However, endovascular repair is a potential treatment that can be used to delay open repair, especially in acutely unstable patients. A case report and review of the literature was conducted to determine whether endovascular therapy could be a destination therapy for patients with arterial rupture secondary to infection.
  
  
  METHODS
  We present the case of a 72-year-old man with a left common iliac artery aneurysm rupture secondary to Salmonella infection treated with endovascular therapy upon initial presentation. A literature review of PubMed yielded 29 patients with ruptured aortic and iliac infected aneurysms that were initially treated with endovascular repair.
  
  
  RESULTS
  Majority of the patients (76.7%, 23 of 30) were successfully treated with the endovascular treatment and did not require open revision. These patients were often placed on long-term antibiotics.
  
  
  CONCLUSIONS
  The literature review supports endovascular repair with a stent graft as a temporizing measure for infected ruptured arteries in an emergent setting and, in select cases, as a destination therapy.
authors.affiliation: Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
authors.forename: Niti
authors.initials: N
authors.lastname: Shahi
authors.affiliation: Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
authors.forename: Jeontaik J
authors.initials: JJ
authors.lastname: Kwon
authors.affiliation: Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
authors.forename: Mariano
authors.initials: M
authors.lastname: Arosemena
authors.affiliation: Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
authors.forename: Dawn M
authors.initials: DM
authors.lastname: Salvatore
authors.affiliation: Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: DiMuzio
authors.affiliation: Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University Hospitals, Philadelphia, PA, USA babak.abai@jefferson.edu.
authors.forename: Babak
authors.initials: B
authors.lastname: Abai
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000785:Aneurysm, Infected / Q000000981:diagnostic imaging / Q000382:microbiology / Q000601:surgery*; D017542:Aneurysm, Ruptured / Q000000981:diagnostic imaging / Q000382:microbiology / Q000601:surgery*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation; D000072226:Computed Tomography Angiography; D057510:Endovascular Procedures / Q000009:adverse effects / Q000295:instrumentation; D006801:Humans; D017543:Iliac Aneurysm / Q000000981:diagnostic imaging / Q000382:microbiology / Q000601:surgery*; D008297:Male; D011183:Postoperative Complications / Q000209:etiology; D012307:Risk Factors; D012480:Salmonella Infections / Q000175:diagnosis / Q000382:microbiology / Q000601:surgery*; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents